Compare Stocks: ITGR, BDSX, ELV, and PEN

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BDSX Biodesix	$27.70 +1.1%	$23.75	$5.26 ▼ $31.31	$289.10M	0.6	119,779 shs	69,417 shs
ELV Elevance Health	$417.13 -1.7%	$397.37	$274.84 ▼ $436.24	$92.00B	0.69	975,337 shs	1.48 million shs
ITGR Integer	$126.21 +0.1%	$115.55	$62.00 ▼ $126.79	$4.29B	0.62	719,860 shs	515,953 shs
PEN Penumbra	$318.33 -0.5%	$321.53	$221.26 ▼ $362.41	$12.60B	0.7	249,603 shs	500,839 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BDSX Biodesix	+1.59%	+4.66%	+14.17%	+78.73%	+7,204.72%
ELV Elevance Health	+1.52%	+4.35%	+6.03%	+6.85%	+36.26%
ITGR Integer	+0.07%	-0.19%	+0.65%	+38.38%	+24.26%
PEN Penumbra	+0.68%	-0.70%	-2.11%	+0.51%	+16.99%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BDSX Biodesix	$27.70 +1.1%	$23.75	$5.26 ▼ $31.31	$289.10M	0.6	119,779 shs	69,417 shs
ELV Elevance Health	$417.13 -1.7%	$397.37	$274.84 ▼ $436.24	$92.00B	0.69	975,337 shs	1.48 million shs
ITGR Integer	$126.21 +0.1%	$115.55	$62.00 ▼ $126.79	$4.29B	0.62	719,860 shs	515,953 shs
PEN Penumbra	$318.33 -0.5%	$321.53	$221.26 ▼ $362.41	$12.60B	0.7	249,603 shs	500,839 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BDSX Biodesix	+1.59%	+4.66%	+14.17%	+78.73%	+7,204.72%
ELV Elevance Health	+1.52%	+4.35%	+6.03%	+6.85%	+36.26%
ITGR Integer	+0.07%	-0.19%	+0.65%	+38.38%	+24.26%
PEN Penumbra	+0.68%	-0.70%	-2.11%	+0.51%	+16.99%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BDSX Biodesix	2.80	Moderate Buy	$31.33	13.12% Upside
ELV Elevance Health	2.65	Moderate Buy	$440.90	5.70% Upside
ITGR Integer	2.07	Hold	$109.86	-12.95% Downside
PEN Penumbra	2.18	Hold	$367.07	15.31% Upside

Current Analyst Ratings Breakdown

Latest ITGR, BDSX, ELV, and PEN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/8/2026	BDSX Biodesix	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/24/2026	PEN Penumbra	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/21/2026	BDSX Biodesix	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/13/2026	ELV Elevance Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
8/13/2026	ITGR Integer	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold
8/10/2026	BDSX Biodesix	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$27.00 ➝ $35.00
8/6/2026	BDSX Biodesix	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$26.00 ➝ $27.00
8/4/2026	ITGR Integer	Freedom Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/4/2026	ITGR Integer	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$84.00 ➝ $127.00
8/3/2026	ITGR Integer	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
8/3/2026	ITGR Integer	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$110.00 ➝ $127.00

(Data available from 9/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BDSX Biodesix	$102.94M	2.84	N/A	N/A	($0.31) per share	-89.35
ELV Elevance Health	$199.13B	0.45	$37.44 per share	11.14	$198.10 per share	2.11
ITGR Integer	$1.85B	2.31	$10.39 per share	12.15	$49.85 per share	2.53
PEN Penumbra	$1.40B	8.93	$4.31 per share	73.91	$36.45 per share	8.73

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BDSX Biodesix	-$35.26M	-$3.17	N/A	N/A	N/A	-26.97%	-788.19%	-30.33%	11/2/2026 (Estimated)
ELV Elevance Health	$5.66B	$22.50	18.54	14.23	2.18	2.47%	14.64%	5.22%	10/21/2026 (Estimated)
ITGR Integer	$102.81M	$3.66	34.48	18.81	2.40	6.97%	12.79%	6.48%	10/22/2026 (Estimated)
PEN Penumbra	$177.69M	$4.07	78.21	52.01	2.18	10.67%	10.50%	8.17%	11/4/2026 (Estimated)

Latest ITGR, BDSX, ELV, and PEN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q2 2026	BDSX Biodesix	-$0.9018	-$0.71	+$0.1918	-$0.71	$26.03 million	$26.86 million
8/3/2026	Q2 2026	ITGR Integer	$1.38	$1.60	+$0.22	$0.69	$451.07 million	$464.11 million
7/30/2026	Q2 2026	PEN Penumbra	$1.16	$0.88	-$0.28	$0.88	$389.64 million	$390.05 million
7/15/2026	Q2 2026	ELV Elevance Health	$6.21	$7.45	+$1.24	$6.71	$48.88 billion	$49.83 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BDSX Biodesix	N/A	N/A	N/A	N/A	N/A
ELV Elevance Health	$6.88	1.64%	+12.47%	30.58%	14 Years
ITGR Integer	N/A	N/A	N/A	N/A	N/A
PEN Penumbra	N/A	N/A	N/A	N/A	N/A

Latest ITGR, BDSX, ELV, and PEN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/14/2026	ELV Elevance Health	quarterly	$1.72	1.65%	9/10/2026	9/10/2026	9/25/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BDSX Biodesix	5.12	2.85	2.85
ELV Elevance Health	0.68	1.52	1.52
ITGR Integer	0.75	3.73	2.41
PEN Penumbra	0.01	5.75	3.86

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BDSX Biodesix	20.96%
ELV Elevance Health	89.24%
ITGR Integer	99.29%
PEN Penumbra	88.88%

Insider Ownership

Company	Insider Ownership
BDSX Biodesix	23.20%
ELV Elevance Health	0.34%
ITGR Integer	1.10%
PEN Penumbra	2.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BDSX Biodesix	334	10.55 million	8.10 million	No Data
ELV Elevance Health	97,100	216.87 million	216.13 million	Optionable
ITGR Integer	11,000	33.99 million	33.62 million	Optionable
PEN Penumbra	4,700	39.39 million	38.25 million	Optionable

ITGR, BDSX, ELV, and PEN Headlines

Recent News About These Companies

Penumbra, Inc. (NYSE:PEN) Receives Consensus Rating of "Hold" from Analysts

September 14 at 2:28 AM | americanbankingnews.com

Penumbra, Inc. (NYSE:PEN) Given Consensus Recommendation of "Hold" by Analysts

September 14 at 2:28 AM | marketbeat.com

Engineers Gate Manager LP Purchases 14,086 Shares of Penumbra, Inc. $PEN

September 13 at 4:08 AM | marketbeat.com

TFX vs. PEN: Which Stock Is the Better Value Option?

September 11, 2026 | zacks.com

Amundi Has $34.70 Million Position in Penumbra, Inc. $PEN

September 11, 2026 | marketbeat.com

Penumbra Launches Link Clot Capture Device for Vascular Thrombectomy

September 10, 2026 | evtoday.comE

California State Teachers Retirement System Has $13.67 Million Stock Position in Penumbra, Inc. $PEN

September 10, 2026 | marketbeat.com

Squarepoint Ops LLC Sells 9,393 Shares of Penumbra, Inc. $PEN

September 9, 2026 | marketbeat.com

February 2027 lunar eclipse will be widely visible but barely noticeable

September 9, 2026 | msn.com

Penumbra, Inc. $PEN Shares Sold by Hsbc Holdings PLC

September 8, 2026 | marketbeat.com

Washington Trust Advisors Inc. Lowers Stock Holdings in Penumbra, Inc. $PEN

September 7, 2026 | marketbeat.com

Odyssean LLC Buys 4,932 Shares of Penumbra, Inc. $PEN

September 5, 2026 | marketbeat.com

Public Employees Retirement System of Ohio Buys Shares of 10,939 Penumbra, Inc. $PEN

September 5, 2026 | marketbeat.com

THE PENUMBRA Cast Album To Be Released This Month

September 4, 2026 | broadwayworld.com

The Manufacturers Life Insurance Company Invests $6.32 Million in Penumbra, Inc. $PEN

August 31, 2026 | marketbeat.com

11,740 Shares in Penumbra, Inc. $PEN Acquired by Canada Pension Plan Investment Board

August 31, 2026 | marketbeat.com

Harvest Management LLC Acquires 39,487 Shares of Penumbra, Inc. $PEN

August 30, 2026 | marketbeat.com

Legal & General Group Plc Buys New Stake in Penumbra, Inc. $PEN

August 30, 2026 | marketbeat.com

Connor Clark & Lunn Investment Management Ltd. Buys New Position in Penumbra, Inc. $PEN

August 30, 2026 | marketbeat.com

Deutsche Bank AG Makes New $1.34 Million Investment in Penumbra, Inc. $PEN

August 30, 2026 | marketbeat.com

Mint Tower Capital Management B.V. Makes New $1.58 Million Investment in Penumbra, Inc. $PEN

August 29, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ITGR, BDSX, ELV, and PEN Company Descriptions

Biodesix NASDAQ:BDSX

$27.70 +0.30 (+1.09%)

Closing price 04:00 PM Eastern

Extended Trading

$27.90 +0.21 (+0.74%)

As of 07:30 PM Eastern

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Elevance Health NYSE:ELV

$417.13 -7.11 (-1.68%)

Closing price 03:59 PM Eastern

Extended Trading

$418.50 +1.37 (+0.33%)

As of 08:00 PM Eastern

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Integer NYSE:ITGR

$126.20 +0.08 (+0.06%)

Closing price 03:59 PM Eastern

Extended Trading

$126.22 +0.02 (+0.01%)

As of 07:30 PM Eastern

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Penumbra NYSE:PEN

$318.33 -1.53 (-0.48%)

Closing price 03:59 PM Eastern

Extended Trading

$318.44 +0.11 (+0.04%)

As of 07:30 PM Eastern

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ITGR, BDSX, ELV, and PEN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ITGR, BDSX, ELV, and PEN Earnings

Compare Dividends

Latest ITGR, BDSX, ELV, and PEN Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ITGR, BDSX, ELV, and PEN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ITGR, BDSX, ELV, and PEN Company Descriptions

Biodesix NASDAQ:BDSX

Elevance Health NYSE:ELV

Integer NYSE:ITGR

Penumbra NYSE:PEN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools